Radiation Dose Optimisation Software Market Report 2026

The radiation dose optimisation software market size has grown rapidly in recent years. It will grow from $1.38 billion in 2025 to $1.55 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to increasing demand for motion-adaptive radiation therapy, growing adoption of advanced imaging systems, rising focus on minimizing treatment errors, expanding use of real-time patient monitoring, increasing preference for high-precision radiotherapy.

The radiation dose optimisation software market size is expected to see rapid growth in the next few years. It will grow to $2.46 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to growing investment in next-generation radiotherapy technologies, increasing adoption of 4D treatment systems, rising demand for accurate tumor-tracking solutions, expanding integration of ai-enabled motion management, increasing need for personalized radiation therapy. Major trends in the forecast period include technology advancements in motion-synchronized radiotherapy systems, innovations in real-time imaging capabilities, developments in adaptive treatment delivery platforms, research and development in tumor-tracking technologies, advancements in imaging-guided radiotherapy solutions.

The increasing emphasis on personalized and precision radiation therapy is expected to drive the growth of the radiation dose optimization software market in the coming years. Personalized and precision radiation therapy involves tailoring radiation doses, delivery techniques, and treatment plans to a patient’s specific tumor characteristics and anatomy. This approach is gaining traction as clinicians aim to maximize tumor control while minimizing damage to surrounding healthy tissue by customizing dose, targeting, and timing according to individual tumor biology and anatomy. Radiation dose optimization software supports this approach by calculating and adjusting radiation doses based on a patient’s unique anatomy and tumor profile. It enhances treatment efficacy and safety by improving tumor targeting while reducing exposure to healthy tissues. For example, in May 2024, the UK Department for Health and Social Care reported that all National Health Service radiotherapy departments in England received artificial intelligence technology through £15.5 million in government funding. This technology automatically reviews scans to distinguish cancerous cells from healthy organs 2.5 times faster than previous methods, reflecting the growing adoption of precision radiotherapy techniques. Consequently, the rising focus on personalized and precision radiation therapy is fueling the growth of the radiation dose optimization software market.

Major companies in the radiation dose optimization software market are focusing on obtaining regulatory clearances for advanced products, such as AI-driven dose calculation engines, to improve clinical efficiency, enhance treatment precision, and reduce manual planning effort and potential errors. AI-driven dose calculation engines are sophisticated software algorithms that use artificial intelligence to automate and optimize radiation dose planning for cancer therapy. For example, in March 2025, DOSIsoft SA, a France-based medical software company, received Food and Drug Administration (FDA) clearance for PLANET Onco Dose version 3.2. This comprehensive, cloud-native treatment planning system features a patented AI-powered dose engine that automates complex calculations, significantly reducing the time required for plan creation. It includes automatic structure-guided optimization and auto-planning functionality, allowing seamless adaptation to varying tumor geometries and patient anatomies with minimal physicist intervention. Additionally, it incorporates workflow automation tools and efficient resource management, increasing clinical throughput and reducing operational costs for oncology departments.

In April 2025, Sun Nuclear Corporation, a US-based provider of radiation therapy quality assurance and oncology software solutions, acquired Oncospace Inc. for an undisclosed amount. Through this acquisition, Sun Nuclear aims to integrate Oncospace’s AI-powered treatment planning conversion and predictive plan quality software into its radiation therapy portfolio, enhancing precision and efficiency in dose optimization and treatment planning workflows. Oncospace Inc. is a US-based developer of a cloud-native, AI-powered software platform designed to help radiation oncology clinicians improve treatment planning and outcomes.

Major companies operating in the radiation dose optimisation software market are Bayer AG, Siemens Healthineers AG, Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., Bracco Imaging S.p.A., Agfa-Gevaert Group, Carestream Health Inc., Guerbet SA, Sectra AB, Landauer Inc., Canon Medical Systems Corporation, Intelerad Medical Systems Inc., PTW Freiburg GmbH, Koninklijke Philips N.V., Ion Beam Applications S.A., PACSHealth LLC, QAELUM N.V., Virtual Phantoms Inc., Medsquare SAS, INFINITT Healthcare Co. Ltd.

North America was the largest region in the radiation dose optimisation software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiation dose optimisation software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the radiation dose optimisation software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the radiation dose optimisation software market by increasing costs of imported it hardware, servers, networking equipment, and integrated imaging interfaces required for software deployment. hospitals and diagnostic centers in north america and europe are most affected due to reliance on imported healthcare it infrastructure, while asia-pacific faces cost pressure on system integrations. these tariffs are raising total implementation costs and slowing upgrade cycles. however, they are also encouraging localized software development, regional hosting solutions, and greater adoption of cloud-based platforms that reduce dependency on imported physical infrastructure.

Radiation dose optimization software refers to digital solutions that monitor, manage, and reduce the radiation exposure patients receive during diagnostic imaging and interventional procedures. Its primary purpose is to enhance patient safety by optimizing imaging protocols, maintaining image quality while minimizing unnecessary radiation, and ensuring compliance with regulatory dose limits.

The primary components of radiation dose optimization software are software and services. Software includes advanced dose management and optimization platforms designed to minimize radiation exposure while maintaining diagnostic and therapeutic image quality across imaging and treatment procedures. These solutions support modalities such as X-ray or digital radiography, fluoroscopy, computed tomography, mammography, and nuclear medicine, deployed through cloud-based, hybrid, and on-premise models, used in diagnostic imaging, radiotherapy, and nuclear medicine applications, among end users such as hospitals, diagnostic centers, ambulatory surgical centers, and research institutes.

The radiation dose optimisation software market consists of revenues earned by entities by providing services such as real-time dose monitoring, treatment plan evaluation, patient-specific dose calculation, radiation safety assessment, clinical workflow integration, predictive analytics for dose reduction, and technical support and training. The market value includes the value of related goods sold by the software provider or included within the software offering. The radiation dose optimisation software market consists of sales of dose calculation and management software, treatment plan evaluation tools, real-time dose monitoring systems, and patient-specific dose optimization platforms. Values in this market are ‘factory gate’ values, representing the worth of goods sold by the manufacturers or creators of the software, whether to other entities or directly to end customers. The value of goods in this market includes related services sold by the creators of the software.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.